GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (ASX:EPN) » Definitions » YoY EBITDA Growth

Epsilon Healthcare (ASX:EPN) YoY EBITDA Growth : 103.13% (As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Epsilon Healthcare YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Epsilon Healthcare's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was 103.13%.

Epsilon Healthcare's EBITDA per Share for the six months ended in Jun. 2023 was A$0.00.


Epsilon Healthcare YoY EBITDA Growth Historical Data

The historical data trend for Epsilon Healthcare's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epsilon Healthcare YoY EBITDA Growth Chart

Epsilon Healthcare Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY EBITDA Growth
Get a 7-Day Free Trial -126.67 -25.00 36.47 20.37 16.28

Epsilon Healthcare Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.00 - -77.78 58.33 103.13

Epsilon Healthcare YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Epsilon Healthcare's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(-0.036--0.043)/ | -0.043 |
=16.28 %

Epsilon Healthcare's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (Q: Jun. 2023 )
=(EBITDA per Share (Q: Jun. 2023 )-EBITDA per Share (Q: Jun. 2022 )) / | EBITDA per Share (Q: Jun. 2022 )) |
=(0.001--0.032)/ | -0.032 |
=103.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epsilon Healthcare YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Epsilon Healthcare's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Epsilon Healthcare (ASX:EPN) Business Description

Traded in Other Exchanges
Address
35 Lime Street, Suite 305, Level 3, Sydney, NSW, AUS, 2000
Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Epsilon Healthcare (ASX:EPN) Headlines

No Headlines